A Rare Case of LIG4 Syndrome in a Chinese Girl
Author Information
Author(s): Jiang Chenjia, Wang Wenyang, Li Yazhou, Liu Xiwang, Zhu Zhirui
Primary Institution: Children's Hospital, Zhejiang University School of Medicine
Hypothesis
Hematopoietic stem cell transplantation (HSCT) can mitigate the long-term risk of developing lymphoid malignancies in patients with LIG4 syndrome.
Conclusion
Hematopoietic stem cell transplantation is an effective treatment for LIG4 syndrome, although it does not improve microcephaly or neurodevelopmental delays.
Supporting Evidence
- The child was diagnosed with primary immunodeficiency, pancytopenia, microcephaly, and slow growth and development.
- Genetic testing revealed compound heterozygous variants in the DNA LIG4 gene.
- Hematopoietic stem cell transplantation led to significant improvements in blood cell counts.
Takeaway
A girl with a rare genetic disease called LIG4 syndrome received a special treatment to help her body fight infections and improve her health.
Methodology
The child underwent genetic testing and hematopoietic stem cell transplantation, with follow-up assessments of blood cell counts and chimerism status.
Limitations
The study is based on a single case report, limiting the generalizability of the findings.
Participant Demographics
The participant is a Chinese girl diagnosed with LIG4 syndrome.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website